Alain Baron, MD CEO, Ethos Pharmaceuticals

Alain D. Baron MD has been Consultant of Amylin Pharmaceuticals Inc., since May 2008. Dr. Baron has been Clinical Professor of Medicine at the University of California, San Diego, and Clinical VA Staff Physician at the VA Medical Center, San Diego, since 2001. Dr. Baron served as Senior Vice President of Clinical Research of Amylin Pharmaceuticals Inc., from June 2002 to September 2004 and served as its Senior Vice President of Research from September 2004 to May 2008. Dr. Baron served as Vice President of Clinical Research of Amylin Pharmaceuticals Inc., since December 1999. From 1989 to 2000, Dr. Baron worked for the Indiana University School of Medicine, where he served as Professor of Medicine and Director, Division of Endocrinology and Metabolism. Dr. Baron held academic and clinical positions in the Division of Endocrinology and Metabolism at University of California, San Diego, and the Veterans Administration Medical Center in San Diego. He is the recipient of several prestigious awards for his research in diabetes and vascular disease, including the 1996 Outstanding Clinical Investigator Award from the American Federation for Medical Research, several from the American Diabetes Association, and is a National Institutes of Health MERIT award recipient. He earned his MD from the Medical College of Georgia, Augusta, and completed Postdoctoral studies at the University of California, San Diego.